PHARPHAMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF MALIGNITIES THAT INCLUDE IN COMBINATION A BISPHOSPHONATE, A COX-2 INHIBITOR AND A TAXOL.

摘要

A pharmaceutical composition for the treatment of prostate cancer, multiple myeloma (MM), tumor-induced hypertension (TIH), bone metastasis (BM) associated with breast cancer, lung cancer, colon cancer or prostate cancer, which comprises , in combination, a bisphosphonate, a COX-2 inhibitor and a taxol or derivative thereof.